SIUT Common issues in ethical review of research: a Pakistani perspective Rana Muzaffar, PhD Department of Microbiology and Immunology Sindh Institute.

Slides:



Advertisements
Similar presentations
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Advertisements

Informed consent in research ethics
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Your Clinical Research Knowledge  B Smith, ORI, 2012.
Phase O Trials: Ethical Considerations Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman Institute.
Identifiability: A Useful or Decrepit Concept in Research Ethics? Sara C. Hull, PhD Faculty, Clinical Center Department of Bioethics Director, NHGRI Bioethics.
AHRQ Informed Consent and Authorization Toolkit for Minimal Risk Research Cindy Brach Agency for Healthcare Research and Quality Center for Delivery, Organization,
Conflict of Interest (COI) and the Consent Process Role of the Physician/ Investigator.
Subcommittee on Harmonization Mark Barnes David Forster.
Measuring Ethical Goals of Research Oversight Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman.
Objective 4: Explain informed decision-making and the informed consent process.
Behavioral Research Chapter Three Ethical Research.
Clinical Trials Medical Interventions
Turning Questions into Trials: Innovation in Surgical Oncology Jennifer E. Rosen MD FACS Assistant Professor of Surgery and Molecular Medicine Boston University.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
INFORMED CONSENT IN INTERNATIONAL RESEARCH Patricia Marshall, PhD Case Western Reserve University.
Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.
FOUNDATIONS OF NURSING RESEARCH Sixth Edition CHAPTER Copyright ©2012 by Pearson Education, Inc. All rights reserved. Foundations of Nursing Research,
Virginia Li - Photovoice - 10 Nov 2008 Photovoice: Beyond Visual Anthropology Caroline Wang, DrPH, Program Director Public Health Institute, Berkley, California.
Module 2 Sealy Center on Aging What kinds of scholarly products can I produce?
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
Research Bioethics Consultation: More potential than sequencing genomes Benjamin S. Wilfond MD Seattle Children’s Hospital Treuman Katz Center for Pediatric.
Accreditation of Research Programs: How it Might Affect your Research Harvey Murff, M.D., M.P.H. Director of Research Safety GCRC, Vanderbilt University.
Are IRBs Efficient, Effective, or Redundant? David C. Clark, Ph.D. Director, Research Compliance Rush University Center.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Workshop on Health Examination Surveys (HES) Legal and ethical issues Susanna Conti, M. Kanieff, G. Rago Istituto Superiore di Sanità (ISS) (National Public.
IRB and the Community Member How You Can Get Involved Mary Lou Smith Elda Railey Conference Call Series on IRBs and Ethical Issues in Research Co-sponsored.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Collection and use of human biological specimens in research: Is there adequate ethics governance in Africa? Madison T. Little and Francis H. Barchi, PhD.
©Sideview Ethical research publication: who’s responsibility is it? Liz Wager PhD Publications Consultant, Sideview
Primary Care and Community Outreach Research VCOM Institutional Review Board Jim Mahaney, PhD Associate Dean for Biomedical Affairs, Virginia Campus Past.
Task Force on Design and Analysis Introduction to Clinical Research Course Outline Bruce Pihlstrom
Capacity Building in Research Ethics Experiences from Thailand Soraj Hongladarom Department of Philosophy, Chulalongkorn University Bangkok, Thailand.
The Role of IRBs and Ethics Susan Kornetsky, MPH Children’s Hospital, Boston.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
Applicability of principles Reidar K. Lie, MD, PhD Department of Clinical Bioethics, NIH and University of Bergen, Norway.
Identifying current and potential ethical challenges and Dilemmas in HIV prevention Research Ethics in clinical research: challenges linked.
IRB Perspective: Concept of the Community-Wide IRB David C. Clark, PhD Assistant Dean for Clinical Research Medical College of Wisconsin.
$100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 Terms Clinical Trial Facts.
Copyright, 1996 © Dale Carnegie & Associates, Inc. CLINICAL TRIALS AND HUMAN SUBJECT PROTECTION: A PLAINTIFF’S PERSPECTIVE ALAN MILSTEIN SHERMAN SILVERSTEIN.
Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.
Second Annual Medical Research Summit March 25, 2002 Washington, D.C.
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
7. Medical Ethics and research BMS 234 Dr. Maha Al Sedik Dr. Noha Al Said Medical Ethics.
‘One lay person from the community should be on Ethics committee (EC) to represent the differed points of view’ - ICMR 2006, Schedule Y 2005 The Community.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Christine Yalda, J.D., Ph.D. Chair, Human Research Review Committee Grand Valley State University.
Practising medicine in the UK W Kuriyan. Routes into Medicine in UK Undergraduate degree Postgraduate entrance Foreign graduates 1.Non European Union.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
CLINICAL TRIALS.
Research Compliance and Institutional Review Boards
Responsibilities of Sponsor, Investigator and Monitor
Patricia M. Alt, Ph.D. Dept. of Health Science Towson University
International Human Subjects Research
Public Health Practice vs Research: Implications for Preparedness and Disaster Research Review by State Health Department IRBs David Perlman, Ph.D. Former.
FDA’s IDE Decisions and Communications
© 2010 Jones and Bartlett Publishers, LLC
Clinical Trials Medical Interventions
Clinical Trials.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Rieke van der Graaf PhD UMC Utrecht, Julius Center
Elements of a Successful Informed Consent
Session Global Perspectives: Somatic and Germline Therapy, Prevention and Enhancement Applications
Presentation transcript:

SIUT Common issues in ethical review of research: a Pakistani perspective Rana Muzaffar, PhD Department of Microbiology and Immunology Sindh Institute of Urology & Transplantation (SIUT) Karachi Pakistan

SIUT 2 Outline Research scenario in Pakistan Issues  Training deficiencies  Misinformed consent  Conflicting interests  Review process

SIUT 3 Research scenario in Pakistan There are 32 randomized controlled trials registered with clinicaltrials.gov 10 are being conducted by one pharmaceutical company 10 are being conducted by one private university 8 are being conducted by US NIH Institutes or Centers

SIUT 4 National Bioethics Committee under Pakistan Medical Research Council (PMRC) OHRP ( International Compilation of Human Subject Research Protection) recognizes 12 IRBs Institutional mechanisms: EMRO study, 24 out of 68 institutions had ERC Capacity for safeguard: Pakistan

SIUT 5

SIUT 6 Issues

SIUT 7 Training deficiencies Undergraduate and postgraduate Lack of opportunities Dearth of capacity Over-training versus non exposure

SIUT 8 Informed consent process Consent forms Lengthy and complex, difficult to read translation in native language Disclaimer/ legalistic rather than an informative document Irrelevant information; insurance, nonexistent support services, regulations etc. Ambiguity about care availability during research; absence of support services in rural areas not addressed

SIUT 9 Informed consent process Lack of real choice for participants Take it or leave it option Social considerations Male dominated decision making; husband, father, son decide Community leaders decide for communities Should IRBs take these factors into consideration?

SIUT 10 Misinformed consent Confusion between research and clinical care “Randomization”, “placebo” or “control”, “double blind” translated literally  “Placebo” translated as “ineffective drug”

SIUT 11 Conflicting Interests Incentives for researchers Incentives for recruitment

SIUT 12 Conflicting interests: incentives for researchers Level of compensation for Principal Investigator Reward for recruitment of subjects for research officers What is the role of IRB’s in this?

SIUT 13 Mechanism of review Wide variation from institution to institution Quality Time Reliability Open to influence

SIUT 14 Conclusions Training deficiencies Limited capacity to conduct ethics reviews Issues with informed consent Issues with conflict of interest

SIUT 15 Recommendations Enhance IRBs’ capacity to review beyond guidelines Probe potential conflict of interest areas Informed consent should be contextual written for subjects who can read and write verbal and witnessed for subjects who cannot read and write

SIUT 16 Recommendations contd. audio-visual materials, brochures etc. to communicate complex information translations should capture concept Lack of adequate health care infrastructure requires IRBs in developing world to be more vigilant

SIUT 17